Covetrus Inc
F:2NJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Covetrus Inc
Additional Paid In Capital
Covetrus Inc
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Covetrus Inc
F:2NJ
|
Additional Paid In Capital
$12.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Additional Paid In Capital
$177m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Additional Paid In Capital
$278.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
37%
|
|
|
Mckesson Corp
NYSE:MCK
|
Additional Paid In Capital
$8.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Cencora Inc
NYSE:COR
|
Additional Paid In Capital
$6.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
Covetrus Inc
Glance View
Nestled in the heart of the animal health industry, Covetrus Inc. emerged as a formidable force, blending technological expertise with deep-rooted veterinary knowledge. Created in 2019 through the merger of Henry Schein Animal Health and Vets First Choice, this company has swiftly positioned itself as an essential partner for veterinary practitioners. Covetrus provides a comprehensive suite of services designed to streamline operations for veterinary clinics, ranging from practice management software to inventory management systems. The core of their operation focuses on enhancing clinic efficiency and improving patient outcomes, driven by digital innovation that connects clinics effortlessly with critical pharmaceuticals, pet foods, and other essential products. Covetrus's business model thrives on a multi-pronged approach. Revenue streams flow widely from the robust sales of prescription and non-prescription medications, medical supplies, and pet products, underpinned by its vast, integrated distribution network. Moreover, the company's software solutions, which are integral to their service offering, generate additional income through subscription fees and service upgrades. This ability to cross-sell digital and physical products creates a cohesive ecosystem for veterinary professionals, ensuring that Covetrus not only meets day-to-day operational needs but also facilitates long-term growth and competitiveness for its customers. Their strategic positioning within the veterinary supply chain, coupled with a clear focus on enhancing clinical workflows, cements Covetrus's role as an indispensable ally in modern animal healthcare.
See Also
What is Covetrus Inc's Additional Paid In Capital?
Additional Paid In Capital
12.6B
USD
Based on the financial report for Dec 31, 2025, Covetrus Inc's Additional Paid In Capital amounts to 12.6B USD.
What is Covetrus Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
-1%
Over the last year, the Additional Paid In Capital growth was 0%.